Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-24

Clinical Trial Update: Use of Wharton Jelly in Diabetic Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for use of Wharton jelly in diabetic nephropathy across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wharton jelly

Snippet

Sponsor: Sophia Al-Adwan | Conditions: Diabetic Nephropathies | Phase 1, Phase 2 | Status: UNKNOWN